List of works - Kerry Fenwick

A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity

scientific article

A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines

scientific article

A modified method for whole exome resequencing from minimal amounts of starting DNA

scientific article

Abstract 3417: An in vivo functional screen to identify metastasis suppressor genes

article

Abstract 4829: Massively parallel RNA sequencing analysis of micropapillary carcinomas of the breast

article by Rachael Natrajan et al published 15 April 2011 in Cancer Research

Abstract 5076: Integrative genomic and transcriptomic analysis of metaplastic carcinomas of the breast

article by Alan G. Mackay et al published 15 April 2012 in Cancer Research

An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor

scientific article published on 11 February 2014

Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA.

scientific article

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

scientific article

Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer

scientific article

Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study

scientific article published on 06 August 2013

Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

scientific article

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.

scientific article published on 10 May 2018

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells

scientific article

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen

scientific article published on 11 April 2011

Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity

scientific article

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

scientific article

Genomic characterisation of acral melanoma cell lines

scientific article published on July 2012

High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing

scientific article

Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma

scientific article

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

scientific article

Integrated functional, gene expression and genomic analysis for the identification of cancer targets

scientific article

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.

scientific article

Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma

scientific article published on December 2009

Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.

scientific article published in July 2009

PPM1D is a potential therapeutic target in ovarian clear cell carcinomas

scientific article published on 17 March 2009

Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers

scientific article

Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor

article by Louise J Barber et al published 25 January 2013 in Journal of Pathology

The genomic landscape of oesophagogastric junctional adenocarcinoma

scientific article

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

scientific article published on 24 March 2009

Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor

scientific article published on 26 April 2012

Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours

scientific article published on 2 April 2015

List of works by Kerry Fenwick

A genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicity

A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines

A modified method for whole exome resequencing from minimal amounts of starting DNA

Abstract 3417: An in vivo functional screen to identify metastasis suppressor genes

Abstract 4829: Massively parallel RNA sequencing analysis of micropapillary carcinomas of the breast

Abstract 5076: Integrative genomic and transcriptomic analysis of metaplastic carcinomas of the breast

An in vivo functional screen identifies ST6GalNAc2 sialyltransferase as a breast cancer metastasis suppressor

Array CGH using whole genome amplification of fresh-frozen and formalin-fixed, paraffin-embedded tumor DNA.

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer

Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study

Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation

Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance.

Genome-wide barcoded transposon screen for cancer drug sensitivity in haploid mouse embryonic stem cells

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen

Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

Genomic characterisation of acral melanoma cell lines

High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing

Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines

Integrated functional, gene expression and genomic analysis for the identification of cancer targets

Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma.

Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinoma

Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components.

PPM1D is a potential therapeutic target in ovarian clear cell carcinomas

Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers

Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor

The genomic landscape of oesophagogastric junctional adenocarcinoma

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

Whole genome in vivo RNAi screening identifies the leukemia inhibitory factor receptor as a novel breast tumor suppressor

Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours